Tagged with CELL

Despite FDA CAR-T Probe, AstraZeneca Pursues Cell Therapy with Gracell Deal
5 HTA Trends to Watch from UK NICE Chief Executive Samantha Roberts
New FDA Guidance Addresses Challenges with Cell and Gene Manufacturing Comparability and Complexity
Broadening Patient Access to Cell Therapies Through the Standardization and Optimization of Starting Materials
The Long Read: Belgium – One of a Kind
Hassan Herrou – General Manager Middle East & Africa, CSL Behring
Cell & Gene Therapy Approvals & Sector Snapshot 2023
Belgium’s Vaccines Industry: Building on a Seismic Legacy
Paul Stoffels – CEO & Chairman, Galapagos
Hugues Bultot – CEO, Univercells
Maria Fernanda Prado – Managing Director, Janssen Benelux
Hong Kong Enters Cell & Gene Therapy Manufacturing Space with New ATP GMP Centre
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here